Article Details
Retrieved on: 2021-03-18 20:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. Topline data from Phase 2b clinical trial evaluating rNAPc2 as a potential treatment for ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here